Remuneration Committee 

The Company established the Remuneration Committee on September 28, 2011, following the approval of the Board of Directors, and formulated the “Remuneration Committee Charter of Medigen Biotechnology Corp.” The duties of the Remuneration Committee are to formulate and periodically review the policies, systems, standards, and structures for performance evaluation and remuneration of directors and managers, as well as to periodically assess and determine the remuneration of directors and managers. Pursuant to the duties prescribed in the Remuneration Committee Charter, the Committee, in its professional and objective capacity, evaluates the Company's policies and systems for the remuneration of directors and managers, and makes recommendations to the Board of Directors for reference in decision-making. The Committee shall convene at least two regular meetings per year. The Committee has been operating effectively.

On May 28, 2024, the Board of Directors resolved to appoint members of the 6th Remuneration Committee. The 6th Remuneration Committee comprises four members, all of whom are the Company's independent directors: Mr. Shui-Ming Chuang, Mr. Pei-Wei Chen, Ms. Sheue-Rong Lin, and Mr. Chu-Ko Wang. Their term of office is from May 28, 2024 to May 27, 2027. 
 
Name  Role  Education & Experience  Current Position 
Pei-Wei Chen 

Convener & 

Independent Director  
  • M.Acc., National Chung Cheng University  
  • Deputy Manager, Deloitte Touche Tohmatsu CPA Ltd. 
  • CPA, Solomon & Co., CPAs 
  • Lecturer, Department of Accounting, Chungyu Institue of Technology 
  • Lecturer, National Taipei College of Business 
  • CPA, Wei Chuang CPA Firm 
  • CPA, Weide CPAs. 
  • Director, Chun Chuang Wealth Management Consulting Co., Ltd. 
  • Independent Director, Les enphants Co., Ltd. 
Shui-Ming Chuang  Independent Director 
  • LL.B., Department of Law, National Taiwan University
  • Prosecutor, Taiwan Taipei District Prosecutors Office
  • Prosecutor, Taiwan Kaohsiung District Prosecutors Office 
  • Judge, Taiwan Taipei District Court 
  • Judge, Taiwan Banqiao District Court 
  • CEO, Public Health and Liver Disease Prevention and Control Promotion, Liver Disease Prevention and Treatment Research Foundation 
Sheue-Rong Lin  Independent Director 
  • B.A., Public Health, National Taiwan University
  • M.A., Epidemiology Research, Johns Hopkins University 
  • Doctoral research in Epidemiology, National Taiwan University 
  • Director/Division Chief, Centers for Disease Control, Ministry of Health and Welfare 
  • Director, Taoyuan County Health Bureau 
  • Director, Food Hygiene Division, Department of Health, Executive Yuan 
  • Deputy Director-General, Food and Drug Administration, Department of Health, Executive Yuan 
  • Counselor, Department of Health, Executive Yuan
  • Director, New Taipei City Health Bureau 
     
  • CEO, Public Health and Liver Disease Prevention and Control Promotion, Liver Disease Prevention and Treatment Research Foundation 
Jou-Kou Wang  Independent Director 
  • Ph.D., Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University
  • EMBA, Graduate Institute of Business Administration, National Taiwan University
  • Deputy Superintendent, National Taiwan University Hospital 
  • Professor, Department of Pediatrics, College of Medicine, National Taiwan University 
  • Director, Division of Pediatric Cardiology, National Taiwan University Hospital 
  • Director, Division of Pediatric Cardiology, National Taiwan University Hospital 
  • Director/Supervisor, Taiwan Society of Cardiology
  • Independent Director, AnTai Technology Co., Ltd. 
 

Duties of the Remuneration Committee 

The members of the Remuneration Committee are appointed by resolution of the Board of Directors, and more than half of the members shall be independent directors. Members shall exercise the duty of care of a good administrator and be accountable to the Board of Directors. The Committee is responsible for establishing and periodically reviewing performance evaluation standards and remuneration policies, systems, standards, and structures for directors, supervisors, and managers; periodically assessing the achievement of performance goals for directors, supervisors, and managers; and determining their individual remuneration based on the evaluation results. During the most recent fiscal year up to the publication date of the annual report, the Committee has faithfully discharged its duties.
 

Operation of the Remuneration Committee in 2024 (FY113) 

Position  Name  Meetings Attended (B)  By Proxy  Attendance Rate (%) (B/A)  Remarks 
Independent Director  Po-Hsiung Lai  1 0 100.00% Resigned after re-election on May 28, 2024 
Independent Director 
(Convener)		 Shui-Ming Chuang  2 0 100.00%  
Independent Director  Pei-Wei Chen  2 0 100.00%  
Independent Director  Sheue-Rong Lin  2 0 100.00%  
Independent Director  Jou-Kou Wang  1 0 100.00% Newly appointed after re-election on May 28, 2024 
 

Meeting Information of the Remuneration Committee 

Date  Proposal Content  Resolution of the
Remuneration Committee 		 Company's Handling of
the Committee's Opinions 
2024/01/30 Remuneration of Directors and Managers for FY 2024  Approved  Adopted as proposed 
2024/08/09 Remuneration standards and structure for newly appointed directors  Approved  Adopted as proposed